<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Triple-Negative Breast Cancer |</title><link>https://muziouyang.com/tags/triple-negative-breast-cancer/</link><atom:link href="https://muziouyang.com/tags/triple-negative-breast-cancer/index.xml" rel="self" type="application/rss+xml"/><description>Triple-Negative Breast Cancer</description><generator>HugoBlox Kit (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Fri, 16 Feb 2024 00:00:00 +0000</lastBuildDate><image><url>https://muziouyang.com/media/icon_hu_1c0e9cb08cfb822a.png</url><title>Triple-Negative Breast Cancer</title><link>https://muziouyang.com/tags/triple-negative-breast-cancer/</link></image><item><title>A Therapeutic Pretargeting Strategy for Triple-Negative Breast Cancer Based on a Bioorthogonal Reaction and a Self-Assembled Peptide</title><link>https://muziouyang.com/publications/pretargeting-tnbc-bioorthogonal-peptide/</link><pubDate>Fri, 16 Feb 2024 00:00:00 +0000</pubDate><guid>https://muziouyang.com/publications/pretargeting-tnbc-bioorthogonal-peptide/</guid><description/></item></channel></rss>